Themis Medicare Limited

NSE THEMISMED.NS

Themis Medicare Limited Return on Capital Employed (ROCE) for the year ending March 31, 2024: 14.83%

Themis Medicare Limited Return on Capital Employed (ROCE) is 14.83% for the year ending March 31, 2024, a -18.81% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.

Themis Medicare Limited Return on Capital Employed (ROCE) for the year ending March 31, 2023 was 18.26%, a -37.29% change year over year.
Themis Medicare Limited Return on Capital Employed (ROCE) for the year ending March 31, 2022 was 29.13%, a 58.69% change year over year.
Themis Medicare Limited Return on Capital Employed (ROCE) for the year ending March 31, 2021 was 18.35%, a 16.07% change year over year.
Themis Medicare Limited Return on Capital Employed (ROCE) for the year ending March 31, 2020 was 15.81%, a 3,511.46% change year over year.

Key data

Date	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio	Return on Common Equity

NSE: THEMISMED.NS

Themis Medicare Limited

CEO	Dr. Sachin Dinesh Patel CChem., Ph.D.
IPO Date	April 2, 2007
Location	India
Headquarters	11/12 Udyog Nagar Industrial Estate
Employees	1,509
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials Cosmetics Drugstores & Retail Pharmacies Eyewear Personal Care

Description

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations for use in various therapeutic areas, including anti-infective, antimalarial, anti-tuberculosis, cardiology, health and nutrition, oncology, ophthalmology, and pain management. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was incorporated in 1969 and is headquartered in Mumbai, India.

Key trends

Past 5 years